Clinical Trial Update: Pharmacokinetics and Pharmacodynamics of BCT194 in Psoriatic Patients [Phase 1]

View source ↗

Summary

This Phase 1 study reports the pharmacokinetics and pharmacodynamics of the investigational compound BCT-194 in patients with psoriasis. The study, conducted by…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• BCT194

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Psoriasis | Phase 1 | Status: COMPLETED